54
Views
5
CrossRef citations to date
0
Altmetric
Original Research

RGD-modified liposomes enhance efficiency of aclacinomycin A delivery: evaluation of their effect in lung cancer

, , , , &
Pages 4613-4620 | Published online: 11 Aug 2015

References

  • RuoslahtiERGD and other recognition sequences for integrinsAnnu Rev Cell Dev Biol1996126977158970741
  • BougieDWRasmussenMZhuJAsterRHAntibodies causing thrombocytopenia in patients treated with RGD-mimetic platelet inhibitors recognize ligand-specific conformers of αIIb/β3 integrinBlood20121196317632522490676
  • MaDXuXAnSA novel family of RGD-containing disintegrins (Tablysin-15) from the salivary gland of the horsefly Tabanus yao targets αIIbβ3 or αVβ3 and inhibits platelet aggregation and angiogenesisThromb Haemost20111051032104521475772
  • HuangYZhangYWuYExpression, purification, and mass spectrometric analysis of 15N, 13C-labeled RGD-hirudin, expressed in Pichia pastoris, for NMR studiesPLoS One20127e4220722879918
  • MoshaveriniaAChenCXuXBone regeneration potential of stem cells derived from periodontal ligament or gingival tissue sources encapsulated in RGD-modified alginate scaffoldTissue Eng Part A20142061162124070211
  • FolkmanJRole of angiogenesis in tumor growth and metastasisSemin Oncol2002296 Suppl 16151812516034
  • PasqualiniRArapWMcDonaldDMProbing the structural and molecular diversity of tumor vasculatureTrends Mol Med2002856357112470989
  • ZetterBROn target with tumor blood vessel markersNat Biotechnol199715124312449359101
  • DanhierFLe BretonAPréatVRGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosisMol Pharm201292961297322967287
  • GarangerEBoturynDDumyPTumor targeting with RGD peptide ligands – design of new molecular conjugates for imaging and therapy of cancersAnticancer Agents Med Chem2007755255817896915
  • ZitzmannSEhemannVSchwabMArginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivoCancer Res2002625139514312234975
  • NitissJLPourquierPPommierYAclacinomycin A stabilizes topoi-somerase I covalent complexesCancer Res199757456445699377570
  • WangJMaitaniYTakayamaKAntitumor effects and pharmacokinetics of aclacinomycin A carried by injectable emulsions composed of vitamin E, cholesterol, and PEG-lipidJ Pharm Sci2002911128113411948551
  • ChenZDengJZhaoYTaoTCyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in ratsInt J Nanomedicine201273803381122888235
  • ChengLHuangFZChengLFGE11-modified liposomes for non-small cell lung cancer targeting: preparation, ex vitro and in vivo evaluationInt J Nanomedicine2014992193524611009
  • JiaYJiJWangFShiLYuJWangDFormulation, characterization, and in vitro/vivo studies of aclacinomycin A-loaded solid lipid nano-particlesDrug Deliv1152014 Epub ahead of print
  • MasakaTMatsudaTLiYSynthesis of VIP-lipopeptide using a new linker to modify liposomes: Towards the devel opment of a drug delivery system for active targetingChem Pharm Bull (Tokyo)2013611184118723979293
  • WangXLinYZengYSunXGongTZhangZEffects of mycophenolic acid-glucosamine conjugates on the base of kidney targeted drug deliveryInt J Pharm201345622323423973508
  • PehlivanSBNanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseasesPharm Res2013302499251123959851
  • AriasJLLiposomes in drug delivery: a patent review (2007 – present)Expert Opin Ther Pat2013231399141423957267
  • GaumetMVargasAGurnyRDelieFNanoparticles for drug delivery: the need for precision in reporting particle size parametersEur J Pharm Biopharm2008691917826969
  • DongYFengSSMethoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugsBiomaterials2004252843284914962562
  • XuJZhaoJHLiuYFengNPZhangYTRGD-modified poly(D,L-lactic acid) nanoparticles enhance tumor targeting of oridoninInt J Nanomedicine2012721121922275836